- Ablynx, Karen Heyninck
- Abzena, Campbell Bunce
- Amgen, Dan Mytych
- AstraZeneca, Jo Goodman
- Bayer, Pedro Paz
- BioAgilytix Europe, Frank Horling
- Boehringer Ingelheim, Patrick Garidel
- Byondis, Myrthe Rouwette
- Celerion, Patrick Brennecke
- Covance, James Munday
- Fresenius Kabi, Martin Ullmann
- Genmab, Arnout Gerritsen
- GlaxoSmithKline, Goerge X Gunn
- Hansa Biopharma, Yvonne Stenberg
- ImmunXperts, Sofie Pattijn
- Integrated Biologix GmbH, Sebastian Spindeldreher
- Kamondi Bioanalytical Consultancy GmbH, Szilard Kamondi
- Kromminga Consulting, Arno Kromminga
- Leukocare, Andreas Seidle
- LGC, Deborah McManus
- Lonza, Noel Smith
- Lundbeck, Mikkel Nors Harndal
- Merck Group KgaA, Mantas Malisauskas
- Merck Sharp & Dome, Shuli Zhang
- MSD, Huaping Tang
- Novartis, Claudio Calonder
- Novo Nordisk, Hélène Solberg
- Pfizer, Sophie Tourdot
- Pharming, Simone Talens
- QPS, Monique Putman
- Roche, Gregor Lotz
- Sandoz, Anita Rudy
- Sanofi, Daniel Kramer
- Sanquin, Theo Rispens
- SciPot Consultancy, Melody Janssen
- Shire, Birgit Reipert
- Swedish Orphan Biovitrum AB, Nina Brenden
- Thermo Fisher Scientific, Åsa Marknell DeWitt
- UCB Pharma, John Smeraglia
- Wieslab, a Svar Life Science company, Janka Ryding
Associate members
- Amy Rosenberg
- Vibha Jawa